Literature DB >> 24647879

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT.

Vivek Verma1, Ling Chen, Jeff M Michalski, Yanle Hu, Wenjun Zhang, Kathryn Robinson, Shivam Verma, Laura Eschen, Sandra Fergus, Dan Mullen, Seth Strope, Robert Grubb, Hiram A Gay.   

Abstract

PURPOSE: The purpose of the study was to evaluate the utility of a 3 T pelvic magnetic resonance imaging (MRI) in detecting a local recurrence in post-prostatectomy prostate cancer patients prior to receiving adjuvant or salvage intensity-modulated radiation therapy (IMRT).
METHODS: Ninety prostate cancer patients status post-prostatectomy with rising prostate-specific antigen (PSA) had a 3 T pelvic MRI prior to IMRT. The following variables were analyzed for predicting positive findings on MRI: initial presenting and initial post-op PSA, PSA at the time of imaging, PSA velocity, surgical margins, Gleason score, pathological stage, pre-RT digital rectal examination, and type of surgical prostatectomy.
RESULTS: The only significant variable predictive of a positive MRI was positive margins. Specifically, 15 of 46 (33 %) patients with positive margins had a positive MRI, while 5 of 44 (11 %) patients with negative margins had a positive MRI. In the MRI positive group, the location of the positive findings on MRI corresponded with the pathology report in 9 of 12 (75 %) cases.
CONCLUSION: Post-prostatectomy patients with pathologic positive margins are three times more likely to have positive findings on a 3 T MRI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647879     DOI: 10.1007/s00345-014-1269-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience.

Authors:  Gianluca Giannarini; Daniel P Nguyen; George N Thalmann; Harriet C Thoeny
Journal:  Eur Urol       Date:  2011-11-24       Impact factor: 20.096

2.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors:  Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

Review 3.  Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU).

Authors:  Pasquale Martino; Vincenzo Scattoni; Andrea B Galosi; Paolo Consonni; Carlo Trombetta; Silvano Palazzo; Carmen Maccagnano; Giovanni Liguori; Massimo Valentino; Michele Battaglia; Libero Barozzi
Journal:  World J Urol       Date:  2011-05-08       Impact factor: 4.226

Review 4.  Imaging techniques for local recurrence of prostate cancer: for whom, why and how?

Authors:  O Rouvière
Journal:  Diagn Interv Imaging       Date:  2012-03-30       Impact factor: 4.026

5.  Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.

Authors:  Oguz Akin; David H Gultekin; Hebert Alberto Vargas; Junting Zheng; Chaya Moskowitz; Xin Pei; Dahlia Sperling; Lawrence H Schwartz; Hedvig Hricak; Michael J Zelefsky
Journal:  Eur Radiol       Date:  2011-05-01       Impact factor: 5.315

Review 6.  Advances in imaging in the postoperative patient with a rising prostate-specific antigen level.

Authors:  Hedvig Hricak; Heiko Schöder; Darko Pucar; Eric Lis; Steven C Eberhardt; Chinyere N Onyebuchi; Howard I Scher
Journal:  Semin Oncol       Date:  2003-10       Impact factor: 4.929

7.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

8.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

9.  Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.

Authors:  Maaike R Moman; Cornelis A T van den Berg; Arto E Boeken Kruger; Jan J Battermann; Marinus A Moerland; Uulke A van der Heide; Marco van Vulpen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-03       Impact factor: 7.038

10.  Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience.

Authors:  David A McKenna; Fergus V Coakley; Antonio C Westphalen; Shoujun Zhao; Ying Lu; Emily M Webb; Barby Pickett; Mack Roach; John Kurhanewicz
Journal:  Radiology       Date:  2008-02-07       Impact factor: 11.105

View more
  6 in total

1.  Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?

Authors:  Vivek Verma; Shifeng Chen; Sumin Zhou; Charles A Enke; Andrew O Wahl
Journal:  Strahlenther Onkol       Date:  2016-12-01       Impact factor: 3.621

2.  Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.

Authors:  Berrend G Muller; Aradhana Kaushal; Sandeep Sankineni; Elena Lita; Anthony N Hoang; Arvin K George; Soroush Rais-Bahrami; Jochen Kruecker; Pingkun Yan; Sheng Xu; Jean J de la Rosette; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Urol Oncol       Date:  2015-08-08       Impact factor: 3.498

Review 3.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

Review 4.  Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.

Authors:  Felipe Couñago; Gemma Sancho; Violeta Catalá; Diana Hernández; Manuel Recio; Sara Montemuiño; Jhonathan Alejandro Hernández; Antonio Maldonado; Elia Del Cerro
Journal:  World J Clin Oncol       Date:  2017-08-10

5.  Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy.

Authors:  Minsu Kim; Sung Il Hwang; Hyungwoo Ahn; Hak Jong Lee; Seok Soo Byun; Sung Kyu Hong; Sangchul Lee
Journal:  Prostate Int       Date:  2022-05-12

6.  Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy.

Authors:  D Hernandez; D Salas; D Giménez; P Buitrago; S Esquena; J Palou; P de la Torre; J Pernas; I Gich; G Gómez de Segura; J Craven-Bartle; G Sancho
Journal:  Radiat Oncol       Date:  2015-12-24       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.